Fenofibrate
  
Side effects 
	
		
Options: 
			
			Show MedDRA Preferred Terms,  
				
	                 display all 38 labels
	 			
	 		
		
	
	
| Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 
| Liver function test abnormal | 0.533% - 7.5% | 1.4% | x |  |  | x | x | x |  |  | x | x | x |  |  |  | x | x |  | x | x | x | 
| Unspecified disorder of intestine | common |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Vomiting | common |  |  |  |  |  |  |  |  |  | x | x | x |  | x | x | x | x | x | x | x | x | 
| Abdominal pain | postmarketing — 2.52% - 5.1% | 2.07% - 4.5% | x | x | x | x | x | x | x | x | x | x | x | x | x |  | x | x | x | x | x | x | 
| Upper respiratory tract infection | 2.64% - 5.31% |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Nasopharyngitis | 3.26% - 5.88% |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Pain in extremity | 2.66% - 4.87% |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Malnutrition | 3.77% | 3.63% | x | x |  | x | x | x |  |  | x | x | x |  | x | x | x | x | x | x | x | x | 
| Back pain | 3.27% - 6.52% | 2.5% - 2.8% | x | x | x | x | x | x |  |  |  |  |  | x | x |  | x | x | x | x | x | x | 
| Aspartate aminotransferase increased | 1.07% - 3.4% | 0.5% | x | x | x | x | x | x | x | x | x | x | x | x |  |  | x | x | x | x | x | x | 
| Headache | postmarketing — 0.533% - 16.7% | 2.7% - 3.3% | x | x | x | x | x | x | x | x | x | x | x | x | x |  | x | x | x | x | x | x | 
| Creatine phosphokinase increased | 0.21% - 3% | 1.3% - 1.4% |  |  |  |  | x |  |  |  | x | x | x | x | x |  |  |  |  | x |  | x | 
| Alanine aminotransferase increased | 0.406% - 3.06% | 1.6% | x | x | x | x | x | x | x | x | x | x | x | x |  |  | x | x | x | x | x | x | 
| Pharyngitis | 2.9% | 2.5% |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Dyspepsia | 0.533% - 4.7% | 1.55% - 2.5% |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Fatigue | 2.04% - 3.27% |  |  |  |  |  |  |  | x | x |  |  | x | x |  |  |  |  |  |  |  |  | 
| Pain | 1.43% - 3.47% |  |  |  |  |  |  |  |  |  |  |  |  | x |  | x | x |  | x | x | x | x | 
| Rash | uncommon, 1.5% - 2.31% | 0.75% - 0.777% |  |  |  |  |  |  | x | x | x | x | x |  | x | x | x | x | x | x | x | x | 
| Diarrhoea | common, 0.533% - 6.94% | 3.37% - 4.8% |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Nausea | postmarketing — 0.8% - 5.52% | 1.81% - 2.3% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Rhinitis | 1.1% - 2.7% | 1.04% - 1.8% | x | x | x | x | x | x |  |  |  | x | x | x | x |  | x | x | x | x | x | x | 
| Constipation | 0.533% - 3.27% | 0.777% - 1.5% | x | x | x | x | x | x | x | x | x | x | x | x | x |  | x | x | x | x | x | x | 
| Influenza | 1.7% - 2.1% | 2% - 2.7% |  |  |  |  |  |  |  |  |  |  |  | x | x |  | x | x | x | x | x | x | 
| Flatulence | common, 0.533% - 2.1% | 2.59% |  |  |  |  |  |  | x | x | x | x | x |  | x | x | x | x | x | x | x | x | 
| Pruritus | uncommon, 2.1% | 0.5% - 0.777% |  |  |  |  |  |  | x | x | x | x | x |  | x | x | x | x | x | x | x | x | 
| Chest pain | 1.9% | 1.3% |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Sinusitis | 0.811% - 3.48% | 2.5% |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | 
| Dizziness | 0.533% - 4.08% | 1% - 1.04% |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Accidental injury | 1.5% | 2% |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Malaise | 1.5% | 0.2% |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Bronchitis | 1.3% | 1.3% |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | 
| Conjunctivitis | 1.05% | 1% |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Insomnia | 1.05% | 0.5% |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Urticaria | uncommon, 1.3% | 0% |  |  |  |  |  |  | x | x | x | x | x |  | x | x | x | x | x | x | x | x | 
| Pulmonary embolism | uncommon |  |  |  |  |  |  |  |  |  |  | x | x |  | x |  |  |  |  |  | x | x | 
| Thromboembolism | uncommon |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Deep vein thrombosis | uncommon |  |  |  |  |  |  |  |  |  |  | x | x |  | x |  |  |  |  |  | x | x | 
| Photosensitivity reaction | uncommon |  |  |  |  |  |  |  |  |  | x | x | x |  | x | x | x | x | x | x | x | x | 
| Hepatobiliary disease | uncommon |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Serum creatinine increased | uncommon |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | x | x | 
| Venous thromboembolism | uncommon |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  |  |  |  | 
| Asthenia | postmarketing — 0.533% - 2.94% | 1.81% - 3% |  | x | x | x | x | x | x | x | x | x | x | x | x |  | x | x | x | x | x | x | 
| Libido decreased | 0.533% |  |  |  |  |  |  |  | x | x | x | x | x |  |  | x | x | x | x | x | x | x | 
| Gastritis | 0.533% |  |  |  |  |  |  |  |  |  | x | x | x |  |  | x | x | x | x | x | x | x | 
| Laboratory test abnormal | 0.533% |  |  |  |  |  |  |  |  |  | x | x | x |  |  |  |  |  |  |  |  |  | 
| Cramp muscle | rare, uncommon |  |  |  |  |  |  |  |  | x | x | x | x |  | x |  |  |  |  |  |  |  | 
| Myositis | rare, uncommon |  |  |  |  |  |  |  |  |  | x | x | x |  | x | x | x | x | x | x | x | x | 
| Alopecia | rare |  |  |  |  |  |  |  | x | x | x | x | x |  | x | x | x | x | x | x | x | x | 
| Anaemia | postmarketing |  |  | x | x | x | x | x |  |  |  |  |  | x |  | x | x | x | x | x | x | x | 
| Arthralgia | postmarketing, 1.9% - 4.9% | 1.8% - 2.85% |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Hepatitis | very rare — rare |  |  | x | x | x | x | x | x | x | x | x | x | x | x |  |  |  | x |  |  |  | 
| Renal failure acute | postmarketing |  |  | x | x | x | x | x |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Nervous system disorder | rare |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  |  | 
| Pancreatitis | postmarketing, uncommon |  |  | x | x | x | x | x | x | x |  | x | x | x | x |  |  |  |  |  | x |  | 
| Renal failure | postmarketing |  |  |  | x |  |  | x |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Rhabdomyolysis | very rare, postmarketing |  |  | x | x | x | x | x |  |  | x | x | x | x | x |  |  |  |  |  | x | x | 
| Muscle spasms | postmarketing, 1.63% - 4.89% |  |  | x | x | x | x | x |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Creatinine increased | postmarketing |  |  |  | x |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x |  | x | 
| Myalgia | postmarketing — 0.629% - 6.12% | 1% - 1.04% |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Erythema | very rare |  |  |  |  |  |  |  | x | x | x | x | x |  | x |  |  |  |  |  |  |  | 
| Photosensitivity | very rare |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Amblyopia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Angina pectoris |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Anorexia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Anxiety |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Arrhythmia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Arthritis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Asthma |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Atherosclerosis |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Atrial fibrillation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Mental disorder |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Blister |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Bone disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Breast feeding |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Bursitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Vaginal moniliasis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Cardiovascular disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  | x | x | x | x | 
| Cholecystitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Cholelithiasis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Colitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Infection |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  | x | x | x | x | x | x | x | 
| Connective tissue disorder |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Cough |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Cystitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Dermatitis contact |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Fungal skin infection |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Duodenal ulcer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Dyspnoea |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Dysuria |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Ear pain |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Ecchymosis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Eczema |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Oedema |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Eosinophilia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Eructation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Oesophagitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Eye disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Body temperature increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Gastroenteritis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Gastrointestinal disorder |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | 
| Gout |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Gynaecomastia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Cardiac disorder |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Hernia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Herpes NOS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  | 
| Herpes simplex |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Herpes zoster |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Hypersensitivity |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | x | x | x | x | x | x | x | 
| Hypertension |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  | x | x | x | x | x | x | x | 
| Hypoglycaemia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Hypotension |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Jaundice |  |  |  |  |  |  |  |  |  |  | x | x | x |  | x |  |  |  |  |  | x |  | 
| Arthropathy |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Laryngitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Cramps of lower extremities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Leukopenia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Mediastinal disorder |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  |  | 
| Hypertonia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Myopathy |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Musculoskeletal pain |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Myocardial infarction |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | x | x | x | x | x | x | x | 
| Nail disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Nervousness |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Neuralgia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Otitis media |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Palpitations |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Paraesthesia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Peptic ulcer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Phlebitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Pneumonia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Prostatic disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Rectal disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Refraction disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Skin disorder |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  | x | x | x | x | x | x | x | 
| Skin ulcer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Sweating |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Tachycardia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Tenosynovitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Thrombocytopenia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Tooth disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Unintended pregnancy |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Pollakiuria |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Urinary tract infection |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Varicose vein |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Angiopathy |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  | x | x | x | x | x | x | x | 
| Vasodilation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Vertigo |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Weight increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Weight decreased |  |  |  |  |  |  |  |  |  | x | x | x |  |  |  | x | x | x | x | x | x | x | 
| Dry mouth |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Peripheral vascular disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | 
| Oedema peripheral |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Migraine |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Blood urea increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Cataract specified |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Ventricular extrasystoles |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Gamma-glutamyltransferase increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Kidney function abnormal |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Lactic dehydrogenase activity increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Liver fatty deposition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Muscular weakness |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  | 
| Phosphatase alkaline increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Unspecified disorder of skin and subcutaneous tissue |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Epigastric distress |  |  |  |  |  |  |  |  | x | x | x | x | x |  |  |  |  |  |  |  |  |  | 
| Increased appetite |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Hepatic enzyme increased |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Erectile dysfunction |  |  |  |  |  |  |  |  | x | x | x |  |  |  |  |  |  |  |  |  |  |  | 
| Rectal haemorrhage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Blood bilirubin increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Extrasystoles |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Rash maculo-papular |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Urolithiasis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Lymphadenopathy |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Electrocardiogram abnormal |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Cough increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Cutaneous hypersensitivity |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  |  |  |  | 
| Drug interaction |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Acne |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Hyperuricaemia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Infestation NOS |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Blood and lymphatic system disorders |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  | 
| Pulmonary alveolitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Unwell |  |  |  |  |  |  |  |  |  | x |  |  | x |  |  |  |  |  |  |  |  |  | 
| Thromboembolic event |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | 
| Plasma creatinine increased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  | 
| Pharyngolaryngeal pain |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Raised liver function tests |  |  | x | x |  | x | x | x |  |  |  |  |  |  |  | x |  | x | x | x | x | x | 
| Myasthenia |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Coronary artery disease |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Somnolence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
| Abnormal vision |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 11 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 19 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 19 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 20 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 21 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 21 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 26 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 35 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 36 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 43 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 43 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 45 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 50 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
	  
		| Side effects: | 122 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 132 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 132 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 134 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 134 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 146 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 146 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |